Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Brophy

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Thrombosis and Haemostasis : JTH|July 22, 2014
Failure of corn trypsin inhibitor to affect the thrombin generation assay in plasma from severe hemophiliacsB M Mohammed, E J Martin, V Salinas, et al.
Journal of Women'S Health & Gender-Based Medicine|October 26, 1999
Pharmacotherapy of dyslipidemia in postmenopausal women: weighing the evidenceD F Brophy, M A Crouch, D M Ruffin, et al.
Journal of Thrombosis and Haemostasis : JTH|December 1, 2010
Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patientsH Agersø, D F Brophy, H Pelzer, et al.
Journal of Thrombosis and Haemostasis : JTH|August 12, 2004
Antifactor Xa activity correlates to thrombin generation time, platelet contractile force and clot elastic modulus following ex vivo enoxaparin exposure in patients with and without renal dysfunctionD F Brophy, E J Martin, A M Best, et al.
Journal of Thrombosis and Haemostasis : JTH|January 11, 2016
Allosterism-based simultaneous, dual anticoagulant and antiplatelet action: allosteric inhibitor targeting the glycoprotein Ibα-binding and heparin-binding site of thrombinA Y Mehta, B M Mohammed, E J Martin, et al.
Journal of Thrombosis and Haemostasis : JTH|January 20, 2006
Thrombin generation time is a novel parameter for monitoring enoxaparin therapy in patients with end-stage renal diseaseD F Brophy, E J Martin, T W B Gehr, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 21, 2000
Small and middle molecular weight solute clearance in nocturnal intermittent peritoneal dialysisD F Brophy, K M Sowinski, M A Kraus, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 21, 2013
Monitoring rFVIII prophylaxis dosing using global haemostasis assaysM A Al Hawaj, E J Martin, J Venitz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 28, 2015
Coated platelet assay: a feasible approach to a complicated scienceB M Mohammed, D Contaifer, K K Lastrapes, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteersD F Brophy, D S Israel, A Pastor, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Thrombosis and Haemostasis : JTH|July 22, 2014
Failure of corn trypsin inhibitor to affect the thrombin generation assay in plasma from severe hemophiliacsB M Mohammed, E J Martin, V Salinas, et al.
Journal of Women'S Health & Gender-Based Medicine|October 26, 1999
Pharmacotherapy of dyslipidemia in postmenopausal women: weighing the evidenceD F Brophy, M A Crouch, D M Ruffin, et al.
Journal of Thrombosis and Haemostasis : JTH|December 1, 2010
Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patientsH Agersø, D F Brophy, H Pelzer, et al.
Journal of Thrombosis and Haemostasis : JTH|August 12, 2004
Antifactor Xa activity correlates to thrombin generation time, platelet contractile force and clot elastic modulus following ex vivo enoxaparin exposure in patients with and without renal dysfunctionD F Brophy, E J Martin, A M Best, et al.
Journal of Thrombosis and Haemostasis : JTH|January 11, 2016
Allosterism-based simultaneous, dual anticoagulant and antiplatelet action: allosteric inhibitor targeting the glycoprotein Ibα-binding and heparin-binding site of thrombinA Y Mehta, B M Mohammed, E J Martin, et al.
Journal of Thrombosis and Haemostasis : JTH|January 20, 2006
Thrombin generation time is a novel parameter for monitoring enoxaparin therapy in patients with end-stage renal diseaseD F Brophy, E J Martin, T W B Gehr, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 21, 2000
Small and middle molecular weight solute clearance in nocturnal intermittent peritoneal dialysisD F Brophy, K M Sowinski, M A Kraus, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 21, 2013
Monitoring rFVIII prophylaxis dosing using global haemostasis assaysM A Al Hawaj, E J Martin, J Venitz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 28, 2015
Coated platelet assay: a feasible approach to a complicated scienceB M Mohammed, D Contaifer, K K Lastrapes, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteersD F Brophy, D S Israel, A Pastor, et al.
Pageof 3